StemCore Is First Independent Review Board Specializing In Stem Cell Research Protocols
Main Category: Stem Cell ResearchArticle Date: 24 Jan 2007 - 0:00 PDT
| Patient / Public: | ![]() |
5 (1 votes) |
| Healthcare Prof: | ![]() |
In response to the rapidly evolving field of stem cell research, this month's launch of StemCore marks the establishment of the first independent ethical review board focusing exclusively on stem cell research. StemCore will function as both a Stem Cell Research Oversight Committee (SCRO), as described in several sets of voluntary guidelines for such research, and as an Institutional Review Board (IRB), as required by regulations governing human subjects research.
The StemCore board consists of highly qualified members with significant experience and expertise in molecular biology, genetics, clinical care, ethics, law, policy, clinical research, and the regulatory aspects of basic and clinical research. This combined review eliminates delays, reduces administrative burden, avoids communication problems among boards, and facilitates a streamlined, consistent review of all issues relevant to conducting stem cell research. "It is critical that research in this emerging area of science proceeds as quickly as possible and is subject to independent oversight to ensure ethical and regulatory compliance," said Kathi Hanna, StemCore Co-Chair.
Through its validation process, StemCore can ensure investigators and institutions that the cell lines they are importing or exporting for use in research projects meet all ethical, regulatory, and legal requirements. Moreover, StemCore will create and preserve an electronic dossier of regulatory and supporting documents that verify a cell line's provenance and integrity, which will prove critical in agency approval of breakthrough therapies. "One of the biggest hurdles in the early stages of this research is validating that existing cell lines were procured ethically and consistent with applicable regulations," said Hanna. "StemCore offers a valuable service in facilitating the validation process for each cell line in question."
As an independent SCRO/IRB, StemCore's mission is to facilitate the conduct of scientifically and ethically sound research with no conflicts of interest concerning the validity of cell lines or the review of research protocols.
About StemCore:
StemCore is an independent Stem Cell Research Oversight Committee and duly constituted Institutional Review Board. StemCore was established to conduct streamlined "one-stop" seamless review of stem cell research protocols. The company focuses on the review of research involving stem cells, validation of the provenance of embryonic stem cells, and review of protocols testing cell- based therapies. For more information visit http://www.stemcore.org.
StemCore
http://www.stemcore.org
Visit our stem cell research section for the latest news on this subject.
MLA
13 Feb. 2012. <http://www.medicalnewstoday.com/releases/61467.php>
APA
http://www.medicalnewstoday.com/releases/61467.php.
Please note: If no author information is provided, the source is cited instead.
|
Rate this article: (Hover over the stars then click to rate) |
Patient / Public: |
or |
Health Professional: |
Add Your Opinion
Please note that we publish your name, but we do not publish your email address. It is only used to let you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.
If you write about specific medications or operations, please do not name health care professionals by name.
All opinions are moderated before being included (to stop spam)
Contact Our News Editors
For any corrections of factual information, or to contact the editors please use our feedback form.
![]()
Please send any medical news or health news press releases to:
Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.





